Open-label Comparative Randomized Study of the Efficacy and Safety of Orlistat (Xenical) in Complex Therapy of Obesity and Metabolic Disorders in Adolescents.

Trial Profile

Open-label Comparative Randomized Study of the Efficacy and Safety of Orlistat (Xenical) in Complex Therapy of Obesity and Metabolic Disorders in Adolescents.

Completed
Phase of Trial: Phase III

Latest Information Update: 13 Dec 2016

At a glance

  • Drugs Orlistat (Primary)
  • Indications Obesity
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 05 Sep 2013 Treatment table added.
    • 15 Jun 2011 Actual end date (Feb 2011) added as reported by ClinicalTrials.gov.
    • 15 Jun 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top